Innovation
Alsymo aims to treat patients with pulmonary hypertension
… team. The start-up, named Alsymo, was created in September 2022. Rémi Delansorne, experienced in biopharmaceutical R&D … and corporate strategy, took over as CEO. On 21 December 2022, Alsymo signed an exclusive worldwide license agreement … team. The start-up, named Alsymo, was created in September 2022. Rémi Delansorne, experienced in biopharmaceutical R&D …
Published on: